APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Obesity Management

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pediatric Obesity Management Industry Research Report 2026

22 December 2025123 pages

Choose your research edition.

Industry ResearchPediatric Obesity Management Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Obesity Management Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pediatric Obesity Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Obesity Management Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Obesity Management Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pediatric Obesity Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pediatric Obesity Management is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pediatric Obesity Management is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pediatric Obesity Management include Takeda Pharmaceutical Company, Pfizer, GlaxoSmithKline, VIVUS, Herbalife, F.Hoffmann-La Roche, Ethicon, Inc., Currax Pharmaceuticals and AstraZeneca,, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pediatric Obesity Management market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pediatric Obesity Management Market by Company

Takeda Pharmaceutical Company

Pfizer

GlaxoSmithKline

VIVUS

Herbalife

F.Hoffmann-La Roche

Ethicon, Inc.

Currax Pharmaceuticals

AstraZeneca,

ApolloEndosurgery

Pediatric Obesity Management Segment by Type

Phentermine

Liraglutide

Lorcaserin

Setmelanotide

Others

Pediatric Obesity Management Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Pediatric Obesity Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Obesity Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pediatric Obesity Management manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pediatric Obesity Management by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pediatric Obesity Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pediatric Obesity Management Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pediatric Obesity Management Sales (k units) of Manufacturers (2021-2026) Table 7. Global Pediatric Obesity Management Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pediatric Obesity Management Revenue of Manufacturers (2021-2026) Table 9. Global Pediatric Obesity Management Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pediatric Obesity Management Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Pediatric Obesity Management Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pediatric Obesity Management, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pediatric Obesity Management, Product Type & Application Table 14. Global Pediatric Obesity Management Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pediatric Obesity Management by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Pharmaceutical Company Company Information Table 19. Takeda Pharmaceutical Company Business Overview Table 20. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio Table 22. Takeda Pharmaceutical Company Recent Developments Table 23. Pfizer Company Information Table 24. Pfizer Business Overview Table 25. Pfizer Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Pfizer Pediatric Obesity Management Product Portfolio Table 27. Pfizer Recent Developments Table 28. GlaxoSmithKline Company Information Table 29. GlaxoSmithKline Business Overview Table 30. GlaxoSmithKline Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. GlaxoSmithKline Pediatric Obesity Management Product Portfolio Table 32. GlaxoSmithKline Recent Developments Table 33. VIVUS Company Information Table 34. VIVUS Business Overview Table 35. VIVUS Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. VIVUS Pediatric Obesity Management Product Portfolio Table 37. VIVUS Recent Developments Table 38. Herbalife Company Information Table 39. Herbalife Business Overview Table 40. Herbalife Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Herbalife Pediatric Obesity Management Product Portfolio Table 42. Herbalife Recent Developments Table 43. F.Hoffmann-La Roche Company Information Table 44. F.Hoffmann-La Roche Business Overview Table 45. F.Hoffmann-La Roche Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio Table 47. F.Hoffmann-La Roche Recent Developments Table 48. Ethicon, Inc. Company Information Table 49. Ethicon, Inc. Business Overview Table 50. Ethicon, Inc. Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Ethicon, Inc. Pediatric Obesity Management Product Portfolio Table 52. Ethicon, Inc. Recent Developments Table 53. Currax Pharmaceuticals Company Information Table 54. Currax Pharmaceuticals Business Overview Table 55. Currax Pharmaceuticals Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio Table 57. Currax Pharmaceuticals Recent Developments Table 58. AstraZeneca, Company Information Table 59. AstraZeneca, Business Overview Table 60. AstraZeneca, Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. AstraZeneca, Pediatric Obesity Management Product Portfolio Table 62. AstraZeneca, Recent Developments Table 63. ApolloEndosurgery Company Information Table 64. ApolloEndosurgery Business Overview Table 65. ApolloEndosurgery Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. ApolloEndosurgery Pediatric Obesity Management Product Portfolio Table 67. ApolloEndosurgery Recent Developments Table 68. Global Pediatric Obesity Management Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Pediatric Obesity Management Sales by Region (2021-2026) & (k units) Table 70. Global Pediatric Obesity Management Sales Market Share by Region (2021-2026) Table 71. Global Pediatric Obesity Management Sales by Region (2027-2032) & (k units) Table 72. Global Pediatric Obesity Management Sales Market Share by Region (2027-2032) Table 73. Global Pediatric Obesity Management Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Pediatric Obesity Management Revenue Market Share by Region (2021-2026) Table 75. Global Pediatric Obesity Management Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Pediatric Obesity Management Revenue Market Share by Region (2027-2032) Table 77. North America Pediatric Obesity Management Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 79. North America Pediatric Obesity Management Sales by Country (2027-2032) & (k units) Table 80. North America Pediatric Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Pediatric Obesity Management Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Pediatric Obesity Management Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 84. Europe Pediatric Obesity Management Sales by Country (2027-2032) & (k units) Table 85. Europe Pediatric Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Pediatric Obesity Management Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Pediatric Obesity Management Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 89. Asia Pacific Pediatric Obesity Management Sales by Country (2027-2032) & (k units) Table 90. Asia Pacific Pediatric Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Pediatric Obesity Management Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Pediatric Obesity Management Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 94. South America Pediatric Obesity Management Sales by Country (2027-2032) & (k units) Table 95. South America Pediatric Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Pediatric Obesity Management Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Pediatric Obesity Management Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 99. Middle East and Africa Pediatric Obesity Management Sales by Country (2027-2032) & (k units) Table 100. Middle East and Africa Pediatric Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Pediatric Obesity Management Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 103. Global Pediatric Obesity Management Sales by Type (2027-2032) & (k units) Table 104. Global Pediatric Obesity Management Sales Market Share by Type (2021-2026) Table 105. Global Pediatric Obesity Management Sales Market Share by Type (2027-2032) Table 106. Global Pediatric Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Pediatric Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Pediatric Obesity Management Revenue Market Share by Type (2021-2026) Table 109. Global Pediatric Obesity Management Revenue Market Share by Type (2027-2032) Table 110. Global Pediatric Obesity Management Price by Type (2021-2026) & (US$/unit) Table 111. Global Pediatric Obesity Management Price by Type (2027-2032) & (US$/unit) Table 112. Global Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 113. Global Pediatric Obesity Management Sales by Application (2027-2032) & (k units) Table 114. Global Pediatric Obesity Management Sales Market Share by Application (2021-2026) Table 115. Global Pediatric Obesity Management Sales Market Share by Application (2027-2032) Table 116. Global Pediatric Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Pediatric Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Pediatric Obesity Management Revenue Market Share by Application (2021-2026) Table 119. Global Pediatric Obesity Management Revenue Market Share by Application (2027-2032) Table 120. Global Pediatric Obesity Management Price by Application (2021-2026) & (US$/unit) Table 121. Global Pediatric Obesity Management Price by Application (2027-2032) & (US$/unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Pediatric Obesity Management Distributors List Table 125. Pediatric Obesity Management Customers List Table 126. Pediatric Obesity Management Industry Trends Table 127. Pediatric Obesity Management Industry Drivers Table 128. Pediatric Obesity Management Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pediatric Obesity Management Product Image Figure 5. Global Pediatric Obesity Management Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pediatric Obesity Management Market Size (2021-2032) & (US$ Million) Figure 7. Global Pediatric Obesity Management Sales (2021-2032) & (k units) Figure 8. Global Pediatric Obesity Management Average Price (US$/unit) & (2021-2032) Figure 9. Phentermine Product Image Figure 10. Liraglutide Product Image Figure 11. Lorcaserin Product Image Figure 12. Setmelanotide Product Image Figure 13. Others Product Image Figure 14. Online Pharmacies Product Image Figure 15. Hospital Pharmacies Product Image Figure 16. Retail Pharmacies Product Image Figure 17. Global Pediatric Obesity Management Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Pediatric Obesity Management, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Pediatric Obesity Management Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pediatric Obesity Management Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Pediatric Obesity Management Sales by Region in 2025 Figure 23. Global Pediatric Obesity Management Revenue by Region in 2025 Figure 24. North America Pediatric Obesity Management Market Size by Country in 2025 Figure 25. North America Pediatric Obesity Management Sales Market Share by Country (2021-2032) Figure 26. North America Pediatric Obesity Management Revenue Market Share by Country (2021-2032) Figure 27. United States Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Pediatric Obesity Management Market Size by Country in 2025 Figure 31. Europe Pediatric Obesity Management Sales Market Share by Country (2021-2032) Figure 32. Europe Pediatric Obesity Management Revenue Market Share by Country (2021-2032) Figure 33. Germany Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Pediatric Obesity Management Market Size by Country in 2025 Figure 44. Asia Pacific Pediatric Obesity Management Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Pediatric Obesity Management Revenue Market Share by Country (2021-2032) Figure 46. China Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Pediatric Obesity Management Market Size by Country in 2025 Figure 55. South America Pediatric Obesity Management Sales Market Share by Country (2021-2032) Figure 56. South America Pediatric Obesity Management Revenue Market Share by Country (2021-2032) Figure 57. Brazil Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Pediatric Obesity Management Market Size by Country in 2025 Figure 61. Middle East and Africa Pediatric Obesity Management Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Pediatric Obesity Management Revenue Market Share by Country (2021-2032) Figure 63. Egypt Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Pediatric Obesity Management Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Pediatric Obesity Management Sales Market Share by Type (2021-2032) Figure 69. Global Pediatric Obesity Management Revenue Market Share by Type (2021-2032) Figure 70. Global Pediatric Obesity Management Price (US$/unit) by Type (2021-2032) Figure 71. Global Pediatric Obesity Management Sales Market Share by Application (2021-2032) Figure 72. Global Pediatric Obesity Management Revenue Market Share by Application (2021-2032) Figure 73. Global Pediatric Obesity Management Price (US$/unit) by Application (2021-2032) Figure 74. Pediatric Obesity Management Value Chain Figure 75. Pediatric Obesity Management Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Pediatric Obesity Management Industry Opportunities and Challenges

Scope & coverage.

Types
  • Phentermine
  • Liraglutide
  • Lorcaserin
  • Setmelanotide
  • Others
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical Company
  • Pfizer
  • GlaxoSmithKline
  • VIVUS
  • Herbalife
  • F.Hoffmann-La Roche
  • Ethicon, Inc.
  • Currax Pharmaceuticals
  • AstraZeneca,
  • ApolloEndosurgery

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pediatric Obesity Management Market Size (2021-2032)
  4. 2.2.2 Global Pediatric Obesity Management Sales (2021-2032)
  5. 2.2.3 Global Pediatric Obesity Management Market Average Price (2021-2032)
  6. 2.3 Pediatric Obesity Management by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Phentermine
  9. 2.3.3 Liraglutide
  10. 2.3.4 Lorcaserin
  11. 2.3.5 Setmelanotide
  12. 2.3.6 Others
  13. 2.4 Pediatric Obesity Management by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Online Pharmacies
  16. 2.4.3 Hospital Pharmacies
  17. 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pediatric Obesity Management Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pediatric Obesity Management Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Obesity Management Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Obesity Management Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pediatric Obesity Management Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pediatric Obesity Management, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pediatric Obesity Management, Product Type & Application
  8. 3.8 Global Manufacturers of Pediatric Obesity Management, Established Date
  9. 3.9 Global Pediatric Obesity Management Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda Pharmaceutical Company
  2. 4.1.1 Takeda Pharmaceutical Company Company Information
  3. 4.1.2 Takeda Pharmaceutical Company Business Overview
  4. 4.1.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio
  6. 4.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 4.2 Pfizer
  8. 4.2.1 Pfizer Company Information
  9. 4.2.2 Pfizer Business Overview
  10. 4.2.3 Pfizer Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Pfizer Pediatric Obesity Management Product Portfolio
  12. 4.2.5 Pfizer Recent Developments
  13. 4.3 GlaxoSmithKline
  14. 4.3.1 GlaxoSmithKline Company Information
  15. 4.3.2 GlaxoSmithKline Business Overview
  16. 4.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 GlaxoSmithKline Pediatric Obesity Management Product Portfolio
  18. 4.3.5 GlaxoSmithKline Recent Developments
  19. 4.4 VIVUS
  20. 4.4.1 VIVUS Company Information
  21. 4.4.2 VIVUS Business Overview
  22. 4.4.3 VIVUS Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 VIVUS Pediatric Obesity Management Product Portfolio
  24. 4.4.5 VIVUS Recent Developments
  25. 4.5 Herbalife
  26. 4.5.1 Herbalife Company Information
  27. 4.5.2 Herbalife Business Overview
  28. 4.5.3 Herbalife Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Herbalife Pediatric Obesity Management Product Portfolio
  30. 4.5.5 Herbalife Recent Developments
  31. 4.6 F.Hoffmann-La Roche
  32. 4.6.1 F.Hoffmann-La Roche Company Information
  33. 4.6.2 F.Hoffmann-La Roche Business Overview
  34. 4.6.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio
  36. 4.6.5 F.Hoffmann-La Roche Recent Developments
  37. 4.7 Ethicon, Inc.
  38. 4.7.1 Ethicon, Inc. Company Information
  39. 4.7.2 Ethicon, Inc. Business Overview
  40. 4.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ethicon, Inc. Pediatric Obesity Management Product Portfolio
  42. 4.7.5 Ethicon, Inc. Recent Developments
  43. 4.8 Currax Pharmaceuticals
  44. 4.8.1 Currax Pharmaceuticals Company Information
  45. 4.8.2 Currax Pharmaceuticals Business Overview
  46. 4.8.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio
  48. 4.8.5 Currax Pharmaceuticals Recent Developments
  49. 4.9 AstraZeneca,
  50. 4.9.1 AstraZeneca, Company Information
  51. 4.9.2 AstraZeneca, Business Overview
  52. 4.9.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 AstraZeneca, Pediatric Obesity Management Product Portfolio
  54. 4.9.5 AstraZeneca, Recent Developments
  55. 4.10 ApolloEndosurgery
  56. 4.10.1 ApolloEndosurgery Company Information
  57. 4.10.2 ApolloEndosurgery Business Overview
  58. 4.10.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 ApolloEndosurgery Pediatric Obesity Management Product Portfolio
  60. 4.10.5 ApolloEndosurgery Recent Developments
5 Global Pediatric Obesity Management Market Scenario by Region
  1. 5.1 Global Pediatric Obesity Management Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pediatric Obesity Management Sales by Region: 2021-2032
  3. 5.2.1 Global Pediatric Obesity Management Sales by Region: 2021-2026
  4. 5.2.2 Global Pediatric Obesity Management Sales by Region: 2027-2032
  5. 5.3 Global Pediatric Obesity Management Revenue by Region: 2021-2032
  6. 5.3.1 Global Pediatric Obesity Management Revenue by Region: 2021-2026
  7. 5.3.2 Global Pediatric Obesity Management Revenue by Region: 2027-2032
  8. 5.4 North America Pediatric Obesity Management Market Facts & Figures by Country
  9. 5.4.1 North America Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pediatric Obesity Management Sales by Country (2021-2032)
  11. 5.4.3 North America Pediatric Obesity Management Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pediatric Obesity Management Market Facts & Figures by Country
  16. 5.5.1 Europe Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pediatric Obesity Management Sales by Country (2021-2032)
  18. 5.5.3 Europe Pediatric Obesity Management Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pediatric Obesity Management Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pediatric Obesity Management Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pediatric Obesity Management Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pediatric Obesity Management Market Facts & Figures by Country
  41. 5.7.1 South America Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pediatric Obesity Management Sales by Country (2021-2032)
  43. 5.7.3 South America Pediatric Obesity Management Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pediatric Obesity Management Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pediatric Obesity Management Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pediatric Obesity Management Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pediatric Obesity Management Sales by Type (2021-2032)
  2. 6.1.1 Global Pediatric Obesity Management Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Pediatric Obesity Management Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pediatric Obesity Management Revenue by Type (2021-2032)
  5. 6.2.1 Global Pediatric Obesity Management Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pediatric Obesity Management Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pediatric Obesity Management Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pediatric Obesity Management Sales by Application (2021-2032)
  2. 7.1.1 Global Pediatric Obesity Management Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Pediatric Obesity Management Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pediatric Obesity Management Revenue by Application (2021-2032)
  5. 7.2.1 Global Pediatric Obesity Management Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pediatric Obesity Management Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pediatric Obesity Management Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pediatric Obesity Management Value Chain Analysis
  2. 8.1.1 Pediatric Obesity Management Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pediatric Obesity Management Production Mode & Process
  5. 8.2 Pediatric Obesity Management Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pediatric Obesity Management Distributors
  8. 8.2.3 Pediatric Obesity Management Customers
9 Global Pediatric Obesity Management Analyzing Market Dynamics
  1. 9.1 Pediatric Obesity Management Industry Trends
  2. 9.2 Pediatric Obesity Management Industry Drivers
  3. 9.3 Pediatric Obesity Management Industry Opportunities and Challenges
  4. 9.4 Pediatric Obesity Management Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst